CYSTARAN is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by Leadiant Biosciences, Inc.. The primary component is Cysteamine Hydrochloride.
| Product ID | 54482-020_626d1e1b-6394-4d4e-b13f-ef4d96b89ba0 |
| NDC | 54482-020 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CYSTARAN |
| Generic Name | Cysteamine Hydrochloride |
| Dosage Form | Solution |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2012-12-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA200740 |
| Labeler Name | Leadiant Biosciences, Inc. |
| Substance Name | CYSTEAMINE HYDROCHLORIDE |
| Active Ingredient Strength | 7 mg/mL |
| Pharm Classes | Cystine Depleting Agent [EPC], Cystine Disulfide Reduction [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-02-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA200740 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-12-30 |
| Ingredient | Strength |
|---|---|
| CYSTEAMINE HYDROCHLORIDE | 6.5 mg/mL |
| SPL SET ID: | b98ee838-ed23-42a9-93b5-72579e490fba |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 54482-020 | CYSTARAN | cysteamine hydrochloride |
| 55292-410 | CYSTADROPS | cysteamine hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CYSTARAN 85095017 4407365 Live/Registered |
LEADIANT BIOSCIENCES, INC. 2010-07-28 |
![]() CYSTARAN 85089255 not registered Dead/Abandoned |
Sigma-Tau Pharmaceuticals, Inc. 2010-07-21 |